Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Cell Pathways presents series of apoptosis-inducing antineoplastic agents

Feb. 22, 2001

Improved nucleoside immunomodulators in the ICN pipeline

Feb. 22, 2001

Therapeutic agents for drug addiction, withdrawal, etc., claimed by Knoll

Feb. 22, 2001

Dihydrobenzodiazepines and use in dyslipidemias, diabetes, etc.

Feb. 21, 2001

Recent patent covers metabotropic glutamate receptor antagonists selective for group II/III

Feb. 21, 2001

Sigma receptor ligands and use as antipsychotics, etc., reported by Sanofi-Synthelabo

Feb. 21, 2001

Merck reports compounds with the ability to inhibit cytokine production or activity

Feb. 21, 2001

New treatments for osteoporosis with an indole structure

Feb. 21, 2001

Taisho presents new VEGF receptor antagonists with antiangiogenic/antitumor activity

Feb. 21, 2001

Antibacterial quinolinecarboxylic acid derivatives in development at Wakunaga

Feb. 21, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...